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Background: Previous studies found that low blood magnesium increases the risk of
several diseases such as cardiovascular diseases (CVD), diabetes, and hypertension.
These ailments are associated with declined cognitive function.
Objective: We aimed to examine the association between serum magnesium and
cognitive function among Qatari adults. In addition, we assessed the interaction
relation between low serum magnesium, hypertension, and diabetes in relation to
cognitive function.
Method: Data from 1,000 Qatari participants aged ≥20 years old who participated
in the Qatar Biobank (QBB) Study were analyzed. Serum magnesium was measured
by an automated calorimetric method and suboptimal magnesium was characterized
by <0.85 mmol/l. Cognitive function was determined by measuring the mean reaction
time (MRT) based on a computer-based, self-administered test. Multivariable linear
regression was used to examine the relation between serum magnesium concentrations
and cognitive function.
Results: The prevalence of suboptimal magnesium was 57.1%. Across the four quartiles
of serum magnesium from the lowest to the highest, the regression coefficients (95% CI)
for MRT were 0 (reference),−17.8,−18.3, and−31.9 (95% CI 2.4–3.1; p for trend 0.05).
The presence of hypertension and diabetes significantly increased the MRT. Women with
suboptimal magnesium and hypertension had the highest MRT.
Conclusion: The prevalence of suboptimal magnesium is high in Qatar. There was a
direct association between serum magnesium and cognitive function. Low magnesium
concentrations were associated with a longer MRT.
Keywords: serum magnesium, mean reaction time, cognition, qatar biobank, adults, cross-sectional study
INTRODUCTION
Dementia is a major neurocognitive disorder characterized by a decline in memory, problem-
solving, language, and other cognitive skills (Hugo and Ganguli, 2014). According to the World
Alzheimer Report 2018, 50 million people are living with dementia and it will triple to 152 million
by 2050 (Alzheimer’s Disase International, 2018). Nutrition is an important modifiable factor
that affects cognitive function (Scarmeas et al., 2018). Most of the existing studies found a
beneficial effect of fish, nuts, and fresh vegetable intake on cognition (Scarmeas et al., 2018).
However, the association between individual nutrients intake and cognition is inconclusive
(Scarmeas et al., 2018).
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Magnesium is one of the most abundant cations in the human
body (Jahnen-Dechent and Ketteler, 2012). It is a cofactor for
more than 300 enzymatic reactions. These enzymes function
in regulating blood pressure, controlling blood glucose, and
synthesis of several biomolecules such as proteins, DNA, and
RNA (Gröber et al., 2015). Moreover, magnesium plays a role
in neuromuscular conduction and nerve-impulse transmission.
It also has a protective role against neuronal cell death (Kirkland
et al., 2018). Therefore, magnesium may have a potential role in
neurological disorders (Kirkland et al., 2018).
Magnesium can be found in various food sources such as nuts,
legumes, dairy products, and green leafy vegetables. In modern
society with a high consumption of refined grains and low intake
of vegetables, the intake of magnesium is low (Costello R. et al.,
2016). Serum concentrations of magnesium is used as a marker
of magnesium nutritional status. Studies have shown that low
magnesium can increase the risk of several diseases such as
cardiovascular diseases (CVD; Fang et al., 2016; Azab et al., 2019),
diabetes mellitus, and hypertension (Costello R. et al., 2016).
These diseases are associated with declined cognitive function
(Biessels and Despa, 2018).
Evidence from animal studies supports the role of magnesium
in cognitive function. For example, a study conducted by Xu
et al. (2014) found that magnesium protects cognitive function
and synaptic plasticity by inhibiting GSK-3β in a rat model with
Alzheimer’s disease. However, human studies onmagnesium and
cognition are scarce across the world. Higher dietary magnesium
intake was associated with a reduced risk of developing cognitive
impairment in an 8-year follow-up study in Australia (Cherbuin
et al., 2014). The findings are supported by the fact that
Alzheimer’s disease patients have lower plasma magnesium
concentrations (Barbagallo et al., 2011). In stroke patients,
low serum magnesium concentrations were associated with
post-stroke cognitive impairment (Tu et al., 2018). However,
the relation between magnesium and cognitive function in the
general population is not clear.
A recent study on 9,693 Qatari adults found that subclinical
magnesium deficiency (serum magnesium <0.85 mmol/l) is
common. Low circulating magnesium is positively associated
with prediabetes, diabetes, and hypertension in Qatari adults
(Shi and Abou-Samra, 2019). However, no studies have assessed
the relationship between serum magnesium and cognition in
Qatar, where the prevalence of diabetes is about ∼19% (Al-
Thani et al., 2017a). Therefore the objectives of this study were
to determine the association between serum magnesium and
cognitive function and to assess the interaction relation between
low serum magnesium, hypertension, and diabetes in relation to
cognitive function in Qatari adults.
MATERIALS AND METHODS
Study Population
Adults aged 20 years and above were recruited by Qatar
Biobank (QBB). They were Qatari nationals or were living
in the country for more than 15 years. These subjects were
followed up for every 5 years. The details of the study
design were published elsewhere (Al Kuwari et al., 2015).
Sociodemographic information, lifestyle factors, and dietary
habits were collected using a self-administered questionnaire.
Whereas a nurse interview was used to collect information on
health conditions, family history of the disease, and medication
use. Each participant underwent a health examination at Hamad
Medical Center, Doha.
Body height and weight were measured using a Seca
stadiometer. Blood samples (60 ml) were taken and measured for
a total of 66 biomarkers at the QBB facility. A random sample of
1,000 Qatari participants aged 20 years and older were included
in the current analysis. All the participants had measured
serum magnesium concentration and underwent a cognitive
function test.
Outcome Variable: Cognitive Function
(Mean Reaction Time)
Mean reaction time (MRT) was used as an indicator of
cognitive function. It was measured by a computer-based,
self-administered touch screen test comprising 60 tasks (Al
Kuwari et al., 2015; Lyall et al., 2016). The stimulus used for
the assessment of MRT was visual. In addition to MRT, a
paired episodic memory test was conducted. However, due to
the limited variation of the test results, the memory test was not
included in the current study.
Exposure Variable: Serum Magnesium
Serum Magnesium was assessed by an automated colorimetric
method (Magnesium Gen.2 from Roche Diagnostics,
Indianapolis, IN, USA) in the central lab of QBB (Costello
R. B. et al., 2016). The coefficients of variations are 0.3–0.8%.
Subclinical magnesium deficiency was characterized as serum
magnesium<0.85 mmol/l.
Covariates
Gender, age, education (low: without university degree; high:
with a university degree), smoking (non-smokers, ex-smokers,
and current smokers), leisure-time physical activity level [the
metabolic equivalent of task (MET), recoded as tertiles], and
BMI (overweight was defined as a BMI of 25.0–29.9 kg/m2
and obesity was defined as a BMI of ≥30 kg/m2; Al-Thani
et al., 2019) were used as covariates. The diagnostic criteria for
assessing diabetes were: HbA1c ≥6.5%, random blood glucose
≥11.1 mmol/l, fasting blood glucose≥7 mmol/l, or self-reported
diabetes (American Diabetes Association, 2014). Hypertension
was diagnosed as systolic blood pressure >140 mmHg
and/or diastolic blood pressure >90 mmHg or previous
doctor diagnosis.
Data Analysis
The serum magnesium concentrations were stratified into
gender-specific quartiles. Mean (SD) or percentage were
used to present the sample characteristics. To compare
the differences between quartile sample characteristics, a
Chi-squared test was used for categorical variables and ANOVA
was used for continuous variables. To assess the association
between serum magnesium and MRT, three multivariable
linear regression models were used. Model 1 was adjusted
for gender and age (continuous), Model 2 was further
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TABLE 1 | Sample characteristics by quartiles of serum magnesium concentrations1.
Q1 Q2 Q3 Q4 p-value
N = 294 N = 242 N = 237 N = 227
Magnesium (mmol/l) 0.77 (0.03) 0.82 (0.01) 0.86 (0.01) 0.91 (0.03) <0.001
Age (years) 36.1 (10.3) 35.3 (10.3) 35.9 (10.7) 36.1 (10.0) 0.80
Gender 0.24
Male 152 (51.7%) 113 (46.7%) 129 (54.4%) 106 (46.7%)
Female 142 (48.3%) 129 (53.3%) 108 (45.6%) 121 (53.3%)
Education 0.32
Low 105 (35.7%) 73 (30.3%) 88 (37.3%) 72 (31.7%)
High 189 (64.3%) 168 (69.7%) 148 (62.7%) 155 (68.3%)
Smoking status 0.56
Non-smoker 192 (65.3%) 161 (66.5%) 158 (66.7%) 162 (71.4%)
Current Smoker 53 (18.0%) 45 (18.6%) 48 (20.3%) 41 (18.1%)
Ex-smoker 49 (16.7%) 36 (14.9%) 31 (13.1%) 24 (10.6%)
Leisure time physical activity (MET h/week) 7.9 (32.3) 4.5 (12.8) 7.0 (20.6) 5.2 (16.4) 0.30
BMI (kg/m2) 28.8 (5.5) 28.3 (5.7) 27.6 (5.9) 28.0 (5.8) 0.11
BMI categories 0.084
Normal 69 (23.5%) 71 (29.3%) 85 (35.9%) 68 (30.0%)
Overweight 120 (40.8%) 87 (36.0%) 86 (36.3%) 89 (39.2%)
Obese 105 (35.7%) 84 (34.7%) 66 (27.8%) 70 (30.8%)
Supplement use 188 (63.9%) 143 (59.1%) 145 (61.2%) 138 (60.8%) 0.71
Vitamin D and Calcium supplements use 126 (42.9%) 93 (38.4%) 84 (35.4%) 80 (35.2%) 0.23
HbA1C (%) 5.7 (1.3) 5.5 (0.8) 5.5 (0.7) 5.5 (0.6) 0.002
Hypertension 33 (11.2%) 18 (7.4%) 24 (10.1%) 21 (9.3%) 0.51
Diabetes 46 (16.2%) 27 (11.6%) 21 (9.2%) 22 (10.2%) 0.069
Insulin use 13 (4.4%) 3 (1.2%) 3 (1.3%) 0 (0.0%) 0.001
Diabetes medication use other than insulin 29 (9.9%) 10 (4.1%) 8 (3.4%) 8 (3.5%) 0.002
Hypertension medication use 26 (8.8%) 10 (4.1%) 10 (4.2%) 9 (4.0%) 0.030
Mean reaction time (millisecond) 732 (218) 710 (198) 711 (215) 703 (178) 0.38
1Values are mean (SD) or n (%).
TABLE 2 | Association between serum magnesium concentrations and cognitive function1.
Quartiles of serum magnesium
Q1 Q2 Q3 Q4 p for trend Magnesium (continuous) p
Model 12 0 (reference) −19.9 (−50.9 to 11.1) −16.4 (−47.5 to 14.8) −34.1 (−65.6 to −2.54) 0.049 −198.9 (−391.4 to −6.3) 0.043
Model 23 0 (reference) −17.8 (−48.4 to 12.8) −18.3 (−49.0 to 12.5) −31.9 (−63.0 to −0.82) 0.05 −206.3 (−396.1 to −16.4) 0.033
Model 34 0 (reference) −9.3 (−40.4 to 21.8) −10.7 (−42.2 to 20.8) −24.7 (−56.5 to 7.2) 0.14 −140.1 (−336.2 to 56.1) 0.16
1Values are regression coefficients (95% CI) from multivariable linear regression. 2Adjusted for age and gender. 3Further adjusted for education, smoking, and physical activity. 4Further
adjusted for BMI, diabetes, hypertension, and medication for diabetes and hypertension. p values < 0.05.
adjusted for smoking, education, BMI, and physical activity.
Model 3 was further adjusted hypertension, diabetes and the
for use of medication for hypertension and diabetes. The
interaction between serum magnesium, cognitive function,
and chronic diseases (diabetes and hypertension) was tested
by adding the product terms of the variables in the linear
regression model. To visualize the interaction, a command
(marginsplot) in Stata was used. All the analyses were conducted
using STATA (Version 16, Stata Corporation, College Station,
TX, USA). We considered p-values < 0.05 (2-tailed) as
statistically significant.
RESULTS
Sample Description
The mean age of the sample was 35.8 (SD 10.3) years. The mean
serum magnesium concentration was 0.84 (SD 0.08) mmol/l.
The mean MRT was 715.3 (SD 204.1) milliseconds. Overall,
57.1% of participants had a subclinical magnesium deficiency.
More than half of the participants were highly educated and
33.9% have low education levels. 67.3% of subjects were non-
smokers, 18.7%were smokers and 14%were ex-smokers. Overall,
leisure-time physical activity was low. The majority of the sample
was overweight (38.2%) or obese (32.5%). A total of 61.4% of the
sample reported using supplements. 38.3% were using vitamin
D and calcium supplements. Supplementary Figure S1 shows
the distribution of serum magnesium concentrations among
the study sample. Most of the participants had concentrations
between 0.75–0.9 mmol/l.
Across the quartiles of serum magnesium from the lowest to
the highest, there was no difference in age, gender, education,
and smoking (Table 1). However, insulin use, diabetes oral
medication, and hypertension medication were higher among
people who have low serum magnesium. Age and female
gender were associated with a higher MRT while education
was associated with a lower MRT (Supplementary Figure S2).
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FIGURE 1 | Interaction between serum magnesium concentrations, hypertension, and gender with cognition. Values represent the adjusted mean (SD) of mean
reaction time (MRT) derived from multivariable linear regression. Model adjusted for gender, age, education, BMI, smoking status, leisure-time physical activity,
diabetes, hypertension, and current medication use for hypertension and diabetes.
No association was observed between MRT and smoking and
physical activity.
Association Between Serum Magnesium
With MRT
Serum magnesium concentration was inversely associated with
MRT. After adjusting for sociodemographic characteristics,
lifestyle factors, across the quartiles of serum magnesium, the
regression coefficients (95% CI) for MRT were 0 (reference),
−17.8 (2nd quartile), −18.3 (3rd quartile), and −31.9 (4th
quartile; p for trend 0.05; Table 2). Further adjusting for
hypertension, diabetes, and medication use, the above
association was attenuated and became statistically non-
significant. Similarly, using serum magnesium as a continuous
variable, there was an inverse relationship between magnesium
and MRT before the adjustment of medication use.
Figure 1 illustrated a significant interaction (p = 0.008)
between gender, low serum magnesium, and hypertension in
relation to MRT. Women with suboptimal magnesium and
hypertension had the highest MRT. Although a three-way
interaction between gender, suboptimal magnesium, and
diabetes was not statistically significant (p = 0.173), women
with suboptimal magnesium and diabetes had the highest
MRT (Figure 2). There was a significant interaction between
suboptimal magnesium, gender, and age in relation to MRT
(Figure 3). Among women with suboptimal magnesium, there
was an abrupt increase in the MRT when the age was above
40 years old. No such association was observed in men.
DISCUSSION
In this cross-sectional study, serum magnesium concentration
was inversely associated with MRT. Low serum magnesium
was prevalent in Qatari adults and was associated with longer
MRT. There was a significant interaction between low serum
magnesium, hypertension, and gender in relation to MRT. There
was also an interaction between gender, diabetes, and low serum
magnesium. Those with hypertension and low serummagnesium
concentrations, the MRT was longer in women but not in men.
Our findings are consistent with previous studies on the
association between serum magnesium concentrations and
cognition in both animal and human studies (Allaert et al.,
2016; Serefko et al., 2016; Balmus et al., 2017; Boyle et al., 2017;
Iolascon et al., 2017; Kirkland et al., 2018). In a case-control
study of 30 patients (15 with Alzheimer’s disease and 15 with
mild cognitive impairment) and 15 control participants, lower
magnesium concentrations were found among patients with
Alzheimer’s disease and mild cognitive impairment (Balmus
et al., 2017). Evidence from animal studies supports a link
between circulating magnesium and cognition (Slutsky et al.,
2010; Li et al., 2014; Huang et al., 2018; Tu et al., 2018).
Low magnesium impairs cognition (Tu et al., 2018) and
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FIGURE 2 | Interaction between serum magnesium concentrations, diabetes, and gender with cognition. Values represent the adjusted mean (SD) of MRT derived
from multivariable linear regression. Model adjusted for gender, age, education, BMI, smoking status, leisure-time physical activity, diabetes, hypertension, and
current medication use for hypertension and diabetes.
magnesium supplementation improves cognition in several
studies (Slutsky et al., 2010; Li et al., 2014; Huang et al., 2018).
For example, mice fed with a magnesium-deficient diet showed
impairments in the three types of hippocampus-dependent
memory including contextual, social recognition, and spatial
memories (Noble et al., 2014). In contrast, rats with hepatic
encephalopathy after administration of oral magnesium showed
an improvement in cognitive and locomotor functions by
reducing the brain manganese concentration and regulating
glutamine synthetase (Han et al., 2019).
Human studies on the relationship between magnesium
intake and cognition are limited (Iranpour et al., 2019).
Data from the National Health and Nutrition Examination
Survey (NHANES) showed that magnesium intake was directly
associated with improved cognitive function markers such as
Digital Symbol Substitution, Animal Fluency tests, immediate
recall score, and delayed recall score (Iranpour et al., 2019).
Diets rich in magnesium have shown to be positively associated
with cognition (Shakersain et al., 2018). A study conducted in
Sweden found that subjects who consumed a Nordic Prudent
diet rich in magnesium were associated with an improved
cognitive function (Shakersain et al., 2018). A prospective cohort
study in New York (n = 2148) suggested that Alzheimer’s
Disease risk could be decreased with the adherence to a dietary
pattern characterized by high consumption of magnesium-rich
foods such as fish, vegetables, and fruits (Gu et al., 2010).
Findings from clinical trials also support the beneficial effects
of magnesium on cognition (Cohen-Hagai et al., 2018). In a
recent prospective, randomized, double-blinded study (n = 22), a
positive association between serum and intracellular magnesium
and cognitive performance was observed. Also, magnesium
deficiency was associated with impaired cognition (Cohen-Hagai
et al., 2018). In a 12-week randomized, double-blind, placebo-
controlled, parallel designed trial (n = 44), magnesium has been
shown to have the potential for treating cognitive impairment
(Liu et al., 2016).
The interaction between gender, hypertension/diabetes, and
low serum magnesium is intriguing. Although the mechanisms
are not clear, maintaining adequate circulating magnesium
seems to be especially important in women. Consistent with
previous studies (Hyde, 2016), in this study, women have lower
MRT compared to men. Further studies are needed to elucidate
the mechanisms linking magnesium with cognition. Further
clinical trials are warranted to test the efficacy of magnesium
supplementation in cognition in women with diabetes
and hypertension.
Several mechanisms may explain the association between
magnesium and cognition. First, adequate magnesium is
essential for the prevention and management of diabetes and
hypertension. Diabetes and hypertension (Tadic et al., 2016;
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FIGURE 3 | Interaction between gender, suboptimal serum magnesium, and age in relation to MRT. Values represent the adjusted mean (SD) of MRT derived from
multivariate linear regression. Model adjusted for gender, age, education, BMI, smoking status, leisure-time physical activity, diabetes, hypertension, and current
medication use for hypertension and diabetes.
Biessels and Despa, 2018) are risk factors for cognitive
impairment. In Qatar, the diabetes burden is among one of the
highest in the world (Al-Thani et al., 2017a). Second, magnesium
has antioxidant properties and can reduce the levels of oxidative
stress and inflammation (Zheltova et al., 2016). The latter plays
an important role in brain aging and cognitive function decline
(Walker et al., 2019).
The causes of low serum magnesium in this study may
be multifactorial. Diabetes and hypertension can be significant
contributors to hypomagnesemia. In Qatar, the prevalence of
diabetes was≈19% among adults aged 18–64 years old (Al-Thani
et al., 2017a). The contribution of diet on serum magnesium
levels seems to be small based on a previous study in Qatar.
A dietary pattern using a reduced rank regression method with
serum magnesium as the response variable can only explain
0.9% of the variance of serum magnesium (Shi and Abou-
Samra, 2019). In Qatar, the main source of drinking water is
desalinated seawater. Magnesium concentration in desalinated
water is significantly lower than in non-desalinated municipal
water. For example, desalinated water contained 10.9 mg/l
compared to 18 mg/l in other bottled water (Rowell et al.,
2015). It is not known to what extent the consumption of
desalinated seawater contributes to the low serum magnesium
in Qatar.
On the other hand, based on the dietary patterns in Qatar,
refined cereals/grains were the second most consumed product
in Qatar. Refined grains tend to be low in magnesium. Moreover,
Qataris consume more oils, fats, sugar, and sweets than
non-Qataris (Al-Thani et al., 2017b). This may also contribute
to lower magnesium dietary intake. Further studies are needed
to identify the contributors of serum magnesium. With the
population aging rapidly, in combination with the high burden
of chronic diseases, intervention is needed to prevent cognitive
function decline.
Our study has several strengths. First, the participants
were from the general population in Qatar. Second, because
of the richness of QBB data, we were able to adjust the
analysis for various potential confounding variables. Because
of the cross-sectional study design, the results should not
be viewed in terms of cause and effect. Another limitation
was that the cognitive function test included only MRT. As
QBB started to conduct an MRI brain scan, it will allow
us to examine the relationship between serum magnesium
and brain image in the future. Furthermore, the mean age
of the sample was young. It may not represent the Qatar
population at-large.
CONCLUSION AND FUTURE WORK
There was a direct association between serum magnesium
and cognitive function. Low magnesium concentrations were
associated with a longer MRT. Women with diabetes or
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hypertension were affected the greatest by low magnesium
concentrations. Therefore, they may derive benefits from the
consumption of magnesium-rich foods such as nuts, fish,
leafy vegetables, and legumes. Further longitudinal studies
and clinical trials are needed to verify whether magnesium
intake and supplementation may improve cognitive function in
the population.
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